Inga Hansine Rye
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 7
- Oncology top 10%
- Cancer Cells and Metastasis 3
- HER2/EGFR in Cancer Research 2
- Cancer Immunotherapy and Biomarkers 2
-
- Single-cell and spatial transcriptomics 2
- Gene expression and cancer classification 2
- Genetics top 10%
- Genomic variations and chromosomal abnormalities 2
- Pathology and Forensic Medicine top 10%
-
- Monoclonal and Polyclonal Antibodies Research 2
- Co-authors
- Hege G. RussnesOle Christian LingjærdeAnne‐Lise Børresen‐DaleBjørn NaumeVessela N. KristensenVictor WeigmanPeter MarynenAnders Zetterberg
- Partner nations
- NorwayUnited StatesUnited Kingdom
In The Last Decade
Inga Hansine Rye
12 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 60
- Cancer Research 606
- Oncology 330
- Molecular Biology 628
- Genetics 226
- Pathology and Forensic Medicine 144
Countries citing papers authored by Inga Hansine Rye
This map shows the geographic impact of Inga Hansine Rye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inga Hansine Rye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inga Hansine Rye more than expected).
Fields of papers citing papers by Inga Hansine Rye
This network shows the impact of papers produced by Inga Hansine Rye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inga Hansine Rye. The network helps show where Inga Hansine Rye may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Inga Hansine Rye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 8 | |
| 3 | 2021 | 27 | |
| 4 | 2018 | 17 | |
| 5 | 2018 | 2 | |
| 6 | 2018 | 75 | |
| 7 | 2014 | 8 | |
| 8 | 2014 | 6 | |
| 9 | 2012 | 25 | |
| 10 | 2011 | 226 | |
| 11 | 2011 | 44 | |
| 12 | Allele-specific copy number analysis of tumorsbreakdown → | 2010 | 635 |
| 13 | 2010 | 1 |
About Inga Hansine Rye
Inga Hansine Rye is a scholar working on Cancer Research, Oncology and Toxicology, having authored 13 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (7 papers), Cancer Cells and Metastasis (3 papers), Single-cell and spatial transcriptomics (2 papers), HER2/EGFR in Cancer Research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Genomic variations and chromosomal abnormalities (2 papers) and Gene expression and cancer classification (2 papers). The work is most often cited by research in Cancer Research (606 citations), Oncology (330 citations) and Molecular Biology (628 citations). Inga Hansine Rye has collaborated with scholars based in Norway, United States and United Kingdom. Frequent co-authors include Hege G. Russnes, Ole Christian Lingjærde, Anne‐Lise Børresen‐Dale, Bjørn Naume, Vessela N. Kristensen, Victor Weigman, Peter Marynen, Anders Zetterberg, Silje Nord and Charles M. Perou. Their work appears in journals such as Molecular Oncology, Genome biology, iScience, Genes Chromosomes and Cancer and Acta Oncologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.